These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Lack of effect of glibenclamide on insulin requirements and diabetic control in persons with insulin-dependent diabetes.
    Author: Stocks AE, Ma A, Howlett V, Cameron DP.
    Journal: Med J Aust; 1988 Nov 07; 149(9):472-3. PubMed ID: 3141755.
    Abstract:
    The addition of the sulphonylurea agent, glibenclamide, to the insulin therapy of six patients with insulin-dependent diabetes mellitus was studied in a double-blind cross-over trial. The subjects produced no measurable plasma C-peptide after stimulation with glucagon, weighed within 10% of their ideal body weight and required approximately 1 U/kg per day of insulin. After one month of close supervision while the patients were being managed with diet and insulin therapy alone, glibenclamide, three times a day, or a placebo, was added to the therapy for one month. After a further one-month control period, the alternate agent was administered for one month. No change in the insulin requirement or the glycosylated haemoglobin levels, or in the 24-hour profiles of the plasma glucose and free insulin levels in response to a standard diet, was observed at the end of each treatment period. This study suggests that any enhancement of insulin sensitivity by sulphonylurea treatment in persons with insulin-dependent diabetes mellitus is only minor and clinically-unimportant.
    [Abstract] [Full Text] [Related] [New Search]